TREACE MEDICAL CONCEPTS INC (TMCI) Stock Earnings & Estimates
NASDAQ:TMCI - US89455T1097 - Common Stock
7.25 USD
+0.25 (+3.57%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 141.8M 50.21% | 187.118M 31.96% | 209.357M 11.89% | 231.62M 10.63% | 253.48M 9.44% | 272.74M 7.60% | 364.85M 33.77% | |
| EBITDA YoY % growth | -32.67M -106.64% | -46.076M -41.03% | -47.269M -2.59% | 624.24K 101.32% | 8.573M 1,273.35% | 13.719M 60.03% | 34.374M 150.56% | |
| EBIT YoY % growth | -34.8M -110.91% | -51.428M -47.78% | -55.688M -8.28% | -49.744M 10.67% | -41.41M 16.75% | -38.793M 6.32% | -21.726M 44.00% | |
| Operating Margin | -24.54% | -27.48% | -26.60% | -21.48% | -16.34% | -14.22% | -5.95% | |
| EPS YoY % growth | -0.77 -87.80% | -0.81 -5.19% | -0.85 -4.94% | -0.82 3.80% | -0.70 13.93% | -0.69 2.17% | -0.26 62.96% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.28 -12.20% | -0.01 49.00% | -0.24 2.90% | -0.26 7.47% | -0.24 13.45% | 0.05 1,060.00% | -0.24 1.26% | -0.24 7.48% | -0.21 13.87% | 0.06 25.00% |
| Revenue Q2Q % growth | 50.657M 12.36% | 79.218M 15.30% | 57.995M 10.32% | 52.302M 10.37% | 55.869M 10.29% | 87.822M 10.86% | 62.847M 8.37% | 57.324M 9.60% | 61.71M 10.45% | 93.085M 5.99% |
| EBITDA Q2Q % growth | -4.735M 47.11% | 14.421M 75.54% | -1.68M 87.19% | -2.746M 76.99% | -1.362M 71.24% | 19.199M 33.13% | 1.234M 173.43% | -1.153M 58.03% | 714K 152.43% | 21.185M 10.34% |
| EBIT Q2Q % growth | -17.488M -15.55% | 690.203K 438.34% | -14.306M 8.19% | -15.326M 9.71% | -14.188M 18.87% | 4.682M 578.35% | -13.515M 5.53% | -14.994M 2.16% | -13.739M 3.16% | 6.63M 41.61% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.28 3.45% | -0.29 | 0.01 | 4.79% |
| Q1 2025 Q2Q % growth | -0.25 16.67% | -0.31 | 0.06 | 18.69% |
| Q4 2024 Q2Q % growth | -0.01 90.00% | -0.04 | 0.03 | 74.58% |
| Q3 2024 Q2Q % growth | -0.25 10.71% | -0.28 | 0.03 | 9.78% |
| Q2 2024 Q2Q % growth | -0.29 -45.00% | -0.30 | 0.01 | 1.96% |
| Q1 2024 Q2Q % growth | -0.30 -30.43% | -0.31 | 0.01 | 2.89% |
| Q4 2023 Q2Q % growth | -0.10 -25.00% | -0.09 | -0.01 | -10.69% |
| Q3 2023 Q2Q % growth | -0.28 -27.27% | -0.27 | -0.01 | -5.00% |
| Q2 2023 Q2Q % growth | -0.20 35.48% | -0.24 | 0.04 | 17.73% |
| Q1 2023 Q2Q % growth | -0.23 -43.75% | -0.23 | 0.00 | 1.24% |
| Q4 2022 Q2Q % growth | -0.08 33.33% | -0.14 | 0.06 | 43.98% |
| Q3 2022 Q2Q % growth | -0.22 -83.33% | -0.29 | 0.07 | 24.98% |
| Q2 2022 Q2Q % growth | -0.31 -210.00% | -0.21 | -0.10 | -48.25% |
| Q1 2022 Q2Q % growth | -0.16 -128.57% | -0.21 | 0.05 | 22.54% |
| Q4 2021 Q2Q % growth | -0.12 | -0.01 | -0.11 | -2,252.94% |
| Q3 2021 Q2Q % growth | -0.12 | -0.12 | 0.00 | 1.96% |
| Q2 2021 Q2Q % growth | -0.10 | -0.12 | 0.02 | 18.30% |
| Q1 2021 Q2Q % growth | -0.07 | -0.06 | -0.01 | -14.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 47.387M 6.60% | 47.994M | -607K | -1.26% |
| Q1 2025 Q2Q % growth | 52.57M 2.86% | 53.111M | -541K | -1.02% |
| Q4 2024 Q2Q % growth | 68.708M 10.44% | 68.5M | 208K | 0.30% |
| Q3 2024 Q2Q % growth | 45.086M 10.62% | 44.354M | 732K | 1.65% |
| Q2 2024 Q2Q % growth | 44.455M 5.96% | 43.86M | 595K | 1.36% |
| Q1 2024 Q2Q % growth | 51.108M 21.12% | 50.046M | 1.062M | 2.12% |
| Q4 2023 Q2Q % growth | 62.212M 25.00% | 61.761M | 451K | 0.73% |
| Q3 2023 Q2Q % growth | 40.758M 23.28% | 42.896M | -2.138M | -4.98% |
| Q2 2023 Q2Q % growth | 41.953M 39.98% | 41.665M | 288K | 0.69% |
| Q1 2023 Q2Q % growth | 42.195M 45.25% | 40.03M | 2.165M | 5.41% |
| Q4 2022 Q2Q % growth | 49.77M 48.83% | 45.645M | 4.125M | 9.04% |
| Q3 2022 Q2Q % growth | 33.06M 52.91% | 30.668M | 2.392M | 7.80% |
| Q2 2022 Q2Q % growth | 29.97M 45.13% | 29.206M | 764K | 2.62% |
| Q1 2022 Q2Q % growth | 29.05M 55.26% | 26.554M | 2.496M | 9.40% |
| Q4 2021 Q2Q % growth | 33.44M 38.76% | 32.912M | 528K | 1.60% |
| Q3 2021 Q2Q % growth | 21.62M 51.51% | 21.42M | 200K | 0.93% |
| Q2 2021 Q2Q % growth | 20.65M 166.80% | 19.312M | 1.338M | 6.93% |
| Q1 2021 Q2Q % growth | 18.71M 66.16% | 19.142M | -432K | -2.26% |
| Q4 2020 Q2Q % growth | 24.1M 43.97% | % | ||
| Q3 2020 Q2Q % growth | 14.27M 60.52% | % | ||
| Q2 2020 Q2Q % growth | 7.74M -1.90% | % | ||
| Q1 2020 Q2Q % growth | 11.26M 90.85% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -11.48% | -32.21% | -0.42% | 2.24% |
| Revenue | -0.44% | 1.31% | 0.02% | 0.03% |